ABSTRACT PURPOSE: To highlight two cases of keratoconus with signifi cant variations of corneal curvature during pregnancy that reversed several months after delivery.
1
Currently, cutting edge research is focused on the impact of hormonal infl uences on corneal biomechanical properties. It is well established that thyroid hormones play a crucial role in corneal dehydration and transparency during embryonic development. 2 Moreover, female sex hormones affect distinctly ocular physiology and pathophysiology, particularly during pregnancy. 3 There is evidence that those infl uences may induce signifi cant alterations of the corneal biostability in vitro and exacerbate underlying corneal ectasia. 4 We highlight two cases of keratoconus with significant variations of corneal curvature during pregnancy that reversed after delivery, suggesting that hormonal changes occurring regularly during gestation may have a signifi cant impact on the progression of the disease.
CASE REPORTS CASE 1
A 32-year-old woman in good health and without ophthalmological history was referred for ophthalmic evaluation by an optician because of progressive loss of corrected distance visual acuity (CDVA) and was diagnosed as having bilateral keratoconus. During 20 weeks of gestation of her fi rst pregnancy, CDVA worsened bilaterally. A maximal keratometry value (Kmax) increase of 3.60 diopters (D) in the right eye and 1.00 D in the left eye was observed by Scheimpfl ug imaging (Allegro Oculyzer, Wavelight, Erlanger, Germany). Figure 1 . In the year following the second pregnancy, CDVA and corneal topography remained stable.
CASE 2
A 26-year-old woman in good health and with no ophthalmological history was referred 1 month prior to her fi rst pregnancy because of progressive loss of CDVA with increasing astigmatism over 5 years. Variations in Keratoconus During Pregnancy/Hoogewoud et al
DISCUSSION
Our two cases of keratoconus demonstrated transitory fl uctuations of the corneal topographic data during pregnancy, suggesting that gestational hormonal changes may affect the progression of the disease. In the fi rst case, bilateral topographical deterioration was observed during the fi rst trimester of the fi rst pregnancy. In the second case, improvement of the keratometric values was observed in both eyes at 29 weeks of gestation, when the progesterone level is still superior to the estrogen level. Similar to the fi rst case, this improvement reversed by the end of the pregnancy.
The physiological effects of estrogen, progesterone, and pregnancy on the cornea have not been investigated extensively. Refractive changes during pregnancy are not uncommon, but relevant evidence is still limited. In a study including 83 pregnant women, 12 patients manifested diminished CDVA and had a myopic shift of approximately 0.90 D during pregnancy, which was restored after the lactation period. 5 Park et al. 6 reported an increased rate of contact lens intolerance during pregnancy, due to an increase of corneal curvature. Corneal sensitivity has also been described to decrease during the last trimester of pregnancy. 7 An increase in corneal thickness during pregnancy, 8 at the end of the menstrual cycle, and at the time of ovulation has also been documented. 9 The increased corneal thickness during ovulation is associated with decreased corneal hysteresis and decreased corneal resistant factor. 9 This decreased mechanical resistance occurs during the highest peak of estrogen in the menstruation cycle when the progesterone level is still low, but it has not been observed at the end of the cycle during the second lower peak of estrogen. Whether progesterone has a protective effect on corneal softening is unknown. However, progesterone prevents relaxin and beta-estradiol mediated matrix degradation of fi brocartilaginous tissue in vivo. 10 Corneal biomechanics during pregnancy have not yet been investigated in a study-based manner. Nonetheless, a case of keratoconus progression with development of acute corneal hydrops induced by thyroxinemia has been reported during pregnancy 11 and two cases of pregnancy-associated keratectasia have been described. 12, 13 The ocular effects of relaxin, which is responsible for softening of the pubis during pregnancy, are unknown. During pregnancy, relaxin levels reach a peak at 14 weeks of gestation and remain high during the last half of pregnancy.
14 Relaxin-induced degradation of knee cartilage has been demonstrated in vivo, due to upregulation and activation of matrix metalloproteinases (MMPs). 15 The implication of MMPs in the pathophysiology of keratoconus is well established. 16 The levels of MMPs (especially MMP-1, MMP-2, and MMP-9) in corneal stroma are signifi cantly increased in keratoconus, whereas the level of tissue inhibition of MMP-1 is decreased in keratoconic corneas. 16 In addition, keratoconic corneas demonstrate elevated levels of cathepsins V/L2, -B, and -G, which also play an important role in the matrix degradation occurring in corneal stroma in keratoconus. 16 It is interesting that relaxin concentration shows a preovulatory peak, corresponding to the peak of corneal softening during the menstrual cycle.
On the other hand, MMPs play a crucial role in the process of embryo implantation, regulating the trophoblastic invasion during pregnancy. 17 Human chorionic gonadotropin is produced in the fi rst semester of the pregnancy, inducing an upregulation of MMP secretion by the trophoblast (especially MMP-9). 17 The ovarian extracellular matrix remodeling mediated by MMP is required for the establishment of pregnancy and the pattern of MMP expression during the fi rst trimester of pregnancy resembles that of the corneal extracellular matrix in keratoconus. 
Variations in Keratoconus During Pregnancy/Hoogewoud et al
Our two cases of keratoconus demonstrated variable fl uctuations of the corneal topographic data during pregnancy, suggesting that gestational hormonal changes may affect the progression of the disease. These clinical observations support the clinical hypothesis that progesterone may exert a preventive effect on the progression of keratoconus during the second half of the pregnancy and estrogen alone or combined with other hormones such as relaxin may induce a diminution of the corneal stiffness with subsequent exacerbation of the disease in the fi rst half and at the end of the pregnancy. However, the complex nature of the underlying pathophysiology is still unknown. These topographical alterations appear to be transitory and reversible, because corneal topographic values in both cases reached pregestational levels several months after birth. Therefore, we recommend that physicians be reluctant to perform cross-linking during or directly after pregnancy and wait until the corneal curvature has been stabilized, which occurs several months after delivery.
Further studies are required to delineate the role of hormonal changes during pregnancy in ocular physiology and thereby increase our understanding of the complex interaction between hormonal status and corneal physiology in normal and keratoconic cornea. 
